scispace - formally typeset
M

Michael Lazarus

Researcher at Fresenius Medical Care

Publications -  11
Citations -  488

Michael Lazarus is an academic researcher from Fresenius Medical Care. The author has contributed to research in topics: Hemodialysis & Dialysis. The author has an hindex of 7, co-authored 11 publications receiving 442 citations.

Papers
More filters
Journal ArticleDOI

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes

TL;DR: Attending an options class predialysis was associated with more frequent selection of home dialysis, fewer tunneled HD catheters, and lower mortality risk during the first 90 days of dialysis therapy.
Journal ArticleDOI

Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis

TL;DR: Conversion to treatment with nocturnal hemodialysis associates with favorable clinical features, laboratory biomarkers, and improved survival compared with propensity score-matched controls, notwithstanding the possibility of residual selection bias.
Journal ArticleDOI

Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications.

TL;DR: In a large and representative population of incident US dialysis patients, catheter use remains very high during the first year of HD care and is associated with high mechanical complication and bloodstream infection rates.
Journal ArticleDOI

Depressive symptoms associate with high mortality risk and dialysis withdrawal in incident hemodialysis patients

TL;DR: Depressive symptoms reported within the first 90 days of dialysis were associated with greater dialysis withdrawal and mortality risk over the succeeding year, and further evaluation for and treatment of depression during this early vulnerable period may improve symptoms, increase survival and decrease premature withdrawal from dialysis.
Journal ArticleDOI

Human Immunodeficiency Virus Infection in Hemodialysis Patients

TL;DR: Serologic testing for either screening or case-finding purposes, dialysis procedures, renal transplantation, and seroepidemiologic research must be conducted with great attention to specificity; serum samples frozen for prolonged periods are especially likely to be nonspecifically ELISA positive.